- Condition: Emergency Contraception
Interventions: Drug: Ulipristal Acetate (UPA) + ethinylestradiol/levonorgestrel (Microgynon); Drug: placebo + ethinylestradiol/levonorgestrel
Sponsors: HRA Pharma; HRA Pharma
Recruiting - verified March 2012 - Condition: Acute Lung Injury
Intervention: Other: Microdose of NAP
Sponsors: University of Edinburgh; University of Edinburgh; Medical Research Council
Not yet recruiting - verified January 2012 - Condition: Healthy Volunteer
Interventions: Drug: Marketed paracetamol; Drug: Experimental paracetamol formulation
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Withdrawn - verified March 2012 - Conditions: Influenza; Common Cold
Interventions: Drug: Hot drink remedy; Drug: Paraetamol tablet
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified November 2011 - Condition: Healthy or Stable Chronic Illness
Interventions: Biological: Q/LAIV (MEDI3250); Biological: FluMist/B/Yamagata; Biological: FluMist/B/Victoria
Sponsors: MedImmune LLC; MedImmune LLC
Completed - verified September 2011 - Condition: Travelers' Diarrhea
Interventions: Biological: TD Vaccine System; Biological: TD Vaccine System
Sponsors: Intercell USA, Inc.; Intercell USA, Inc.
Completed - verified March 2012 - Conditions: Hereditary Breast and Ovarian Cancer Syndrome; Lynch Syndrome
Interventions: Other: Telemedicine; Other: Face-to-Face
Sponsors: Duke University; Duke University; Susan G. Komen Breast Cancer Foundation
Completed - verified February 2012 - Condition: Breast Cancer
Intervention: Drug: anastrozole
Sponsors: Queen Mary University of London; Jill Knox
Active, not recruiting - verified April 2012
 |
Join Clinical Trials for Healthy Volunteers in Scotland |
